My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 58

    1.

    Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.

    Bikos V, Darzentas N, Hadzidimitriou A, Davis Z, Hockley S, Traverse-Glehen A, Algara P, Santoro A, Gonzalez D, Mollejo M, Dagklis A, Gangemi F, Bosler DS, Bourikas G, Anagnostopoulos A, Tsaftaris A, Iannitto E, Ponzoni M, Felman P, Berger F, Belessi C, Ghia P, Papadaki T, Dogan A, Degano M, Matutes E, Piris MA, Oscier D, Stamatopoulos K.

    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2012.3. [Epub ahead of print]

    PMID:
    22222599
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.

    Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K, Shiraga T, Goto A, Takamatsu N, Asada Y, Utsunomiya A, Okayama A, Kubuki Y, Shimoda K, Ukai Y, Kurosawa G, Morishita K.

    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.379. [Epub ahead of print]

    PMID:
    22289924
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.

    Cocco C, Di Carlo E, Zupo S, Canale S, Zorzoli A, Ribatti D, Morandi F, Ognio E, Airoldi I.

    Leukemia. 2011 Dec 23. doi: 10.1038/leu.2011.363. [Epub ahead of print]

    PMID:
    22193967
    [PubMed - as supplied by publisher]

    Related citations

    4.

    BCL2 mutations in diffuse large B-cell lymphoma.

    Schuetz JM, Johnson NA, Morin RD, Scott DW, Tan K, Ben-Nierah S, Boyle M, Slack GW, Marra MA, Connors JM, Brooks-Wilson AR, Gascoyne RD.

    Leukemia. 2011 Dec 22. doi: 10.1038/leu.2011.378. [Epub ahead of print]

    PMID:
    22189900
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.

    Merkel O, Kenner L, Turner SD.

    Leukemia. 2011 Dec;25(12):1795-6. doi: 10.1038/leu.2011.295. No abstract available.

    PMID:
    22166914
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.

    Nowakowski GS, LaPlant B, Habermann TM, Rivera CE, Macon WR, Inwards DJ, Micallef IN, Johnston PB, Porrata LF, Ansell SM, Klebig RR, Reeder CB, Witzig TE.

    Leukemia. 2011 Dec;25(12):1877-81. doi: 10.1038/leu.2011.165. Epub 2011 Jul 1.

    PMID:
    21720383
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.

    Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, Chan WC, Fu K.

    Leukemia. 2012 May;26(5):1064-72. doi: 10.1038/leu.2011.305. Epub 2011 Nov 25.

    PMID:
    22116552
    [PubMed - in process]

    Related citations

    8.

    Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.

    Gupta M, Han JJ, Stenson M, Wellik L, Witzig TE.

    Leukemia. 2011 Nov 25. doi: 10.1038/leu.2011.340. [Epub ahead of print]

    PMID:
    22116549
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis.

    Meynet O, Bénéteau M, Jacquin MA, Pradelli LA, Cornille A, Carles M, Ricci JE.

    Leukemia. 2012 May;26(5):1145-7. doi: 10.1038/leu.2011.327. Epub 2011 Nov 11. No abstract available.

    PMID:
    22076465
    [PubMed - in process]

    Related citations

    10.

    Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice.

    Moore CR, Liu Y, Shao C, Covey LR, Morse HC 3rd, Xie P.

    Leukemia. 2012 May;26(5):1122-7. doi: 10.1038/leu.2011.309. Epub 2011 Oct 28. No abstract available.

    PMID:
    22033491
    [PubMed - in process]

    Related citations

    11.

    Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma.

    Ansell SM, Tang H, Kurtin PJ, Koenig PA, Nowakowski GS, Nikcevich DA, Nelson GD, Yang Z, Grote DM, Ziesmer SC, Silberstein PT, Erlichman C, Witzig TE.

    Leukemia. 2012 May;26(5):1046-52. doi: 10.1038/leu.2011.297. Epub 2011 Oct 21.

    PMID:
    22015775
    [PubMed - in process]

    Related citations

    12.

    Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.

    Amé-Thomas P, Le Priol J, Yssel H, Caron G, Pangault C, Jean R, Martin N, Marafioti T, Gaulard P, Lamy T, Fest T, Semana G, Tarte K.

    Leukemia. 2012 May;26(5):1053-63. doi: 10.1038/leu.2011.301. Epub 2011 Oct 21.

    PMID:
    22015774
    [PubMed - in process]

    Related citations

    13.

    Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity.

    Kellner C, Hallack D, Glorius P, Staudinger M, Mohseni Nodehi S, de Weers M, van de Winkel JG, Parren PW, Stauch M, Valerius T, Repp R, Humpe A, Gramatzki M, Peipp M.

    Leukemia. 2012 Apr;26(4):830-4. doi: 10.1038/leu.2011.288. Epub 2011 Oct 18. No abstract available.

    PMID:
    22005785
    [PubMed - in process]

    Related citations

    14.

    High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.

    Launay E, Pangault C, Bertrand P, Jardin F, Lamy T, Tilly H, Tarte K, Bastard C, Fest T.

    Leukemia. 2012 Mar;26(3):559-62. doi: 10.1038/leu.2011.266. Epub 2011 Sep 23. No abstract available.

    PMID:
    21941365
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.

    Fruchon S, Kheirallah S, Al Saati T, Ysebaert L, Laurent C, Leseux L, Fournié JJ, Laurent G, Bezombes C.

    Leukemia. 2012 Apr;26(4):795-805. doi: 10.1038/leu.2011.248. Epub 2011 Sep 16.

    PMID:
    21926965
    [PubMed - in process]

    Related citations

    16.

    Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.

    Dodero A, Spina F, Narni F, Patriarca F, Cavattoni I, Benedetti F, Ciceri F, Baronciani D, Scimè R, Pogliani E, Rambaldi A, Bonifazi F, Dalto S, Bruno B, Corradini P.

    Leukemia. 2012 Mar;26(3):520-6. doi: 10.1038/leu.2011.240. Epub 2011 Sep 9.

    PMID:
    21904377
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.

    Braun FC, Grabarczyk P, Möbs M, Braun FK, Eberle J, Beyer M, Sterry W, Busse F, Schröder J, Delin M, Przybylski GK, Schmidt CA.

    Leukemia. 2011 Sep;25(9):1494-501. doi: 10.1038/leu.2011.101. Epub 2011 May 31.

    PMID:
    21625233
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.

    Xiang H, Noonan EJ, Wang J, Duan H, Ma L, Michie S, Boxer LM.

    Leukemia. 2011 Sep;25(9):1484-93. doi: 10.1038/leu.2011.115. Epub 2011 May 24.

    PMID:
    21606958
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    19.

    MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.

    Ramakrishnan V, Ansell S, Haug J, Grote D, Kimlinger T, Stenson M, Timm M, Wellik L, Halling T, Rajkumar SV, Kumar S.

    Leukemia. 2012 Feb;26(2):340-8. doi: 10.1038/leu.2011.192. Epub 2011 Aug 9.

    PMID:
    21826062
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes.

    Ammerpohl O, Haake A, Pellissery S, Giefing M, Richter J, Balint B, Kulis M, Le J, Bibikova M, Drexler HG, Seifert M, Shaknovic R, Korn B, Küppers R, Martín-Subero JI, Siebert R.

    Leukemia. 2012 Jan;26(1):185-8. doi: 10.1038/leu.2011.194. Epub 2011 Aug 5. No abstract available.

    PMID:
    21818115
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk